Oral iron supplement. For any patient needing iron supplementation for documented iron deficiency. Suitable for certain patients undergoing therapy with erythropoietin.

Each tablet contains 324 mg ferrous fumarate--106.9 mg elemental iron--and 1 mg folic acid. Ferrous fumarate may be better tolerated than ferrous sulfate in some patients.


Renal failure patients and patients who have documented iron deficiency. Patients undergoing erythropoietin therapy who risk iron deficiency.


One to three tablets daily between meals as required to correct iron deficiency, or as prescribed by physician.


Transient bloating, flatulence, constipation, and diarrhea. Ingestion of greater than 400 mg per day of elemental iron can result in nausea and vomiting.


See folic acid precaution under NEPHRO-VITE® + FE


Brown, oval tablets marked RD33.

Tablets in unit dose blister packs of 30. NDC 54391-1313-8.

For use under medical supervision.